Wrinkles

... PharmaLive: Aging Population Drives Healthy Prescription Dermatological Drug Growth REGISTERED USERS PRODUCT MARKETING NEWS Aging Population Drives Healthy Prescription Dermatological Drug Growth Market Set to Reach $11.1 Billion by 2010 NEW YORK, February 14, 2006 /PRNewswire/ - The aging of the worldwide population and a focus on lifestyle treatments that revitalize youthfulness and stave off skin damage are the driving forces behind a healthy prescription dermatological drug market, which should see sales jump to $11.1 billion by 2010, according to a new study from market research firm Kalorama Information, a division of MarketResearch.com, the leading provider of industry-specific market research reports.

With 2005 sales reaching $8.4 billion, The Worldwide Market for Prescription Dermatological Drugs predicts that sales in the antiaging, photodamage, hair treatment, psoriasis, and skin cancer segments will grow further at a rate of 5.7% over the next four years as consumer demand for newer and better derma drugs continues to increase as the aging population struggles to deal with a myriad of skin disorders and diseases.

While sales of prescription acne, Rosacea, dermatitis, seborrhea, and hyperpigmentation/melasma products have continued to perform well-although with slower growth rates during the last five years as many of these drugs are older or have lost patent protection-the overall market has been bolstered by recent trends in cosmeceuticals, a favorite among...

Read more...